IMMUNOBIOLOGY

Scope & Guideline

Advancing the frontiers of immunology and hematology.

Introduction

Immerse yourself in the scholarly insights of IMMUNOBIOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN0171-2985
PublisherELSEVIER GMBH
Support Open AccessYes
CountryGermany
TypeJournal
Convergefrom 1979 to 2024
AbbreviationIMMUNOBIOLOGY / Immunobiology
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHACKERBRUCKE 6, 80335 MUNICH, GERMANY

Aims and Scopes

The journal "Immunobiology" focuses on the intricate interplay between the immune system and various biological processes, emphasizing both basic and applied immunology. Its core areas encompass a wide range of topics related to immune responses, disease mechanisms, and therapeutic interventions.
  1. Immunotherapy and Cancer Immunology:
    Research on the development and efficacy of immunotherapies, including checkpoint inhibitors, CAR T-cell therapies, and vaccines targeting tumor antigens.
  2. Inflammation and Immune Regulation:
    Studies focusing on the mechanisms of inflammation, including cytokine signaling, macrophage polarization, and the role of various immune cells in inflammatory diseases.
  3. Infectious Diseases and Host Response:
    Exploration of immune responses to infectious agents, including mechanisms of pathogen evasion and the host's immune defense strategies.
  4. Autoimmunity and Immune Disorders:
    Investigations into the pathogenesis of autoimmune diseases, including the role of specific immune cells, genetic factors, and environmental triggers.
  5. Biomarkers and Diagnostic Immunology:
    Identification and validation of biomarkers for disease prognosis, diagnosis, and treatment responses, particularly in cancer and infectious diseases.
  6. Complement System and Immunobiology:
    Research into the complement system's role in immune responses, including its involvement in inflammation, pathogen recognition, and tissue damage.
Recent publications in "Immunobiology" reflect emerging trends and themes that highlight the evolving landscape of immunological research. These areas are gaining traction and are likely to shape future investigations.
  1. Precision Medicine in Immunology:
    An increasing focus on personalized and precision medicine approaches, tailoring immunotherapies based on individual genetic and molecular profiles.
  2. Microbiome and Immunity:
    Exploration of the gut microbiome's influence on immune responses, particularly its role in autoimmunity, cancer, and infectious diseases.
  3. Single-cell Immunology:
    Advancements in single-cell technologies are enabling detailed analysis of immune cell heterogeneity and function, providing insights into complex immune responses.
  4. Inflammation and Metabolism:
    Research into the interconnections between metabolic pathways and immune responses, particularly in the context of obesity, diabetes, and chronic inflammatory diseases.
  5. Neuroimmunology:
    Growing interest in the interactions between the immune system and the nervous system, particularly regarding neuroinflammatory diseases and the role of immune cells in neurodegeneration.
  6. Targeted Complement Inhibition:
    Emerging studies focusing on the therapeutic potential of complement inhibitors in various diseases, including autoimmune conditions and cancer.

Declining or Waning

While "Immunobiology" continues to thrive in many areas, certain themes have shown a decline in focus over recent years. These waning scopes suggest a shift in research interests within the immunology community.
  1. Traditional Vaccine Development:
    Research in conventional vaccine development has decreased as interest shifts towards novel vaccine platforms, such as mRNA and vector-based vaccines.
  2. Non-specific Immune Modulation:
    Studies focusing on broad, non-targeted immune modulators are becoming less prominent, as more specific and targeted therapies gain traction.
  3. Animal Models in Immunology:
    While animal studies remain important, there is a noticeable decline in the publication of studies relying solely on traditional animal models, as researchers increasingly utilize in vitro and computational approaches.
  4. Historical Immunological Studies:
    Research that primarily emphasizes historical perspectives or classical immunological concepts is less frequently published, as the field moves toward more innovative and mechanistic studies.

Similar Journals

CELLULAR IMMUNOLOGY

Fostering Innovation in Immunological Science
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0008-8749Frequency: 12 issues/year

CELLULAR IMMUNOLOGY is a prestigious journal published by Academic Press Inc. Elsevier Science, dedicated to advancing the field of immunology. Established in 1970 and converging ongoing research up to 2024, this journal has carved out a significant niche within the academic community, boasting a notable Q2 ranking in the Immunology category and holding a respectable 67th percentile ranking within Scopus for its contributions to the disciplines of Immunology and Microbiology. The journal serves as a vital platform for disseminating high-quality research, reviews, and methodologies that elucidate the intricacies of cellular immune responses, thereby benefiting researchers, professionals, and students alike. Although it does not offer open access, the journal's impact is evidenced by its comprehensive coverage of pioneering studies and ongoing developments in the immunological sciences, positioning it as an essential resource for those seeking to deepen their understanding and engage with the latest findings in cellular immunology.

JOURNAL OF IMMUNOLOGY

Pioneering Research in Immunology
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

Cellular & Molecular Immunology

Exploring the Depths of Cellular Defense
Publisher: CHIN SOCIETY IMMUNOLOGYISSN: 1672-7681Frequency: 12 issues/year

Cellular & Molecular Immunology is a prestigious peer-reviewed journal published by the CHIN SOCIETY IMMUNOLOGY. As a leading journal in the fields of immunology and infectious diseases, it proudly holds a Q1 designation across multiple categories, including Immunology, Allergy, and Medicine (Miscellaneous), reflecting its commitment to excellence and impactful research. With an ISSN of 1672-7681 and an E-ISSN of 2042-0226, the journal has been essential reading since its inception in 2004, continuously gathering insights from cutting-edge studies. It ranks impressively within Scopus, with positions in the 7th, 8th, and 9th percentile in relevant categories, establishing it as a cornerstone for researchers, clinicians, and students alike. The journal offers an extensive range of original research articles, reviews, and clinical studies, ensuring that readers stay at the forefront of immunological discovery. Whether you are interested in basic immunology, infectious diseases, or evolving therapies, Cellular & Molecular Immunology serves as an invaluable resource for advancing your knowledge and engagement in this dynamic field.

International Immunopharmacology

Advancing Research at the Intersection of Immunology and Pharmacology
Publisher: ELSEVIERISSN: 1567-5769Frequency: 12 issues/year

International Immunopharmacology, published by Elsevier, stands as a prominent journal within the disciplines of immunology and pharmacology. With an ISSN of 1567-5769 and an E-ISSN of 1878-1705, this esteemed journal is based in the Netherlands and features a robust commitment to disseminating high-quality research from its inception in 2001 through 2024. The journal has achieved impressive rankings, securing a Q1 category in Pharmacology and Q2 in both Immunology and Immunology and Allergy as of 2023. With its strategic focus on bridging the gap between immunology and pharmacological applications, International Immunopharmacology attracts a diverse readership, including researchers, healthcare professionals, and students interested in the latest advancements in therapeutic agents and immune system modulation. Furthermore, it offers an open access option, enhancing the accessibility and reach of its invaluable content. As a pivotal resource in the field, this journal not only facilitates the exchange of innovative ideas but also fosters a deeper understanding of the complexities of immunopharmacology in today’s research landscape.

Frontiers in Immunology

Shaping the Future of Immunology with Cutting-Edge Research
Publisher: FRONTIERS MEDIA SAISSN: 1664-3224Frequency: 1 issue/year

Frontiers in Immunology is a leading open-access journal published by FRONTIERS MEDIA SA since 2010, dedicated to advancing knowledge in the field of immunology. With an impressive Q1 ranking in both Immunology and Allergy as of 2023, this journal exemplifies excellence in research dissemination, positioning itself among the top 22% of relevant literature in the discipline. The journal, based in Switzerland, emphasizes its commitment to open science by ensuring all published research is freely accessible, fostering collaboration and innovation among researchers, professionals, and students alike. With substantial visibility demonstrated by its ranks within the Scopus database—ranked #52 out of 233 in Immunology and Allergy, and #58 out of 236 in Immunology and Microbiology—Frontiers in Immunology serves as a vital platform for cutting-edge research. Researchers are invited to contribute original investigations and reviews that expand the understanding of immune mechanisms, therapeutic advancements, and clinical applications, making it a cornerstone for those looking to push the boundaries of immunological science.

VIRAL IMMUNOLOGY

Innovating research to combat viral infections through immunology.
Publisher: MARY ANN LIEBERT, INCISSN: 0882-8245Frequency: 10 issues/year

Viral Immunology, published by Mary Ann Liebert, Inc, stands as a prominent journal dedicated to advancing the understanding of the interplay between viral infections and host immune responses. With a strong focus on immunology, molecular medicine, and virology, the journal provides a platform for the dissemination of high-quality research findings and innovative methodologies that could shape the future of these critical fields. Although it currently holds a Q3 rating across its relevant categories and a respectable ranking within the Scopus database, Viral Immunology continues to strive for excellence with a commitment to publishing influential research that informs both academic and clinical practices. The journal accepts submissions in various formats—original research, reviews, and commentaries—catering to a diverse readership that includes researchers, professionals, and students engaged in the biological and medical sciences. Readers can anticipate insightful articles that address urgent challenges in immunological responses to viral infections, paving the way for new therapeutic strategies and public health initiatives.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Elevating Immunology: Where Research Meets Real-World Impact
Publisher: OXFORD UNIV PRESSISSN: 0009-9104Frequency: 12 issues/year

Clinical and Experimental Immunology, published by Oxford University Press, is a premier journal that has been a cornerstone in the field of immunology since its inception in 1966. With an ISSN of 0009-9104 and an E-ISSN of 1365-2249, this journal holds a significant position in academic research, currently ranking in the Q2 category for both Immunology and Allergy (2023). Its impactful contributions are reflected in its Scopus rankings, where it stands at Rank #63 out of 233 in Immunology and Allergy, placing it in the 73rd percentile, and Rank #73 out of 236 in Immunology and Microbiology. Researchers, healthcare professionals, and students will find this journal an invaluable resource for cutting-edge studies, reviews, and clinical advancements in the ever-evolving domain of immunology. While the publication does not offer open-access options, it remains a pivotal platform for disseminating knowledge that impacts both clinical practice and experimental research.

HUMAN IMMUNOLOGY

Pioneering Insights into Immune Responses
Publisher: ELSEVIER SCIENCE INCISSN: 0198-8859Frequency: 12 issues/year

HUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.

Immunotherapy Advances

Fostering collaboration and discovery in the world of immunology.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Immunotherapy Advances, published by Oxford University Press, stands at the forefront of the rapidly evolving field of immunology and microbe interactions, focusing specifically on novel immunotherapeutic strategies and their clinical applications. Established in 2021, this peer-reviewed journal aims to disseminate high-quality research that contributes to the understanding and advancement of immunotherapeutic techniques, potentially transforming patient care in immunology. With a current Scopus rank of #140 out of 236 in the realm of Immunology, placing it in the 40th percentile, Immunotherapy Advances is positioned to be an integral resource for researchers, healthcare professionals, and students eager to stay updated with groundbreaking findings and methodologies. The journal is dedicated to fostering innovative discussions and collaborations, ensuring open access to vital research that influences treatment paradigms globally.

BMC IMMUNOLOGY

Advancing Knowledge in Immunological Research
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Immunology is a prominent open-access journal published by BMC that has been at the forefront of immunological research since its inception in 2000. Based in the United Kingdom, this journal aims to advance the understanding of immune system functions and disorders through high-quality, peer-reviewed articles. With an impressive scope encompassing various facets of immunology, BMC Immunology has earned a Q3 ranking in the Immunology category according to the 2023 category quartiles, demonstrating its growing impact and relevance in the scientific community. Researchers and professionals will find valuable insights in its array of published works, spanning both foundational studies and innovative applications. The journal's commitment to open access ensures that cutting-edge research is freely available, fostering collaboration and advancement in the field. For those looking to stay updated on the latest developments in immunology, BMC Immunology stands as an essential resource for researchers, professionals, and students alike.